PTAB/USPTO Update - October 2023

USPTO News

Notices, Guidance, and Requests

Final Rules

  • There are no new final rules.

Interim Rules

  • There are no new interim rules.

Proposed Rules

  • There are no new proposed rules

Proposed Legislation

  • Medication Affordability and Patent Integrity Act (bill introduced by Representatives Ann M. Kuster, Diana Harshbarger on September 13, 2023 “[t]o require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.”)

  • Prohibiting Adversarial Patents Act of 2023 (bill introduced on September 14, 2023 “[t]o amend title 35, United State Code, to require the Director of the United States Patent and Trademark Office to require disclosures in patent applications regarding ties to the People’s Republic of China and other foreign adversaries, and for other purposes.”)

PTAB Decisions

  • New Precedential PTAB Decisions 

    • There are no new informative PTAB decisions.

  • New Informative PTAB Decisions 

    • There are no new informative PTAB decisions.

  • Director Review Decisions 

    • There are no new director review decisions.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© WilmerHale | Attorney Advertising

Written by:

WilmerHale
Contact
more
less

WilmerHale on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide